IDEXX Laboratories Inc (NASDAQ:IDXX) shares are trading higher after the company released better-than-expected fourth-quarter 2023 financial results. Animal diagnostic company reported adjusted EPS of $2.32, beating the consensus of $2.12. The company reported sales of $901.60 million, beating the consensus of $891.25 million. The sales increased 9% compared to the prior year period on a reported basis and 8% on an organic basis, driven by Companion Animal Group (CAG) growth of 10% reported and 9% organic. CAG Diagnostics recurring revenue gains of 11% reported and 10% organic in the quarter w…